Metoprolol Succinate Tablet, Film Coated, Extended Release
Product Images NDC 82009-113

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 82009-113). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container25mg (Container25mg)

Label for Metoprolol Succinate Extended-Release Tablets, USP, 25 mg strength, oral film-coated tablets. The label indicates a package size of 500 tablets, manufactured by Quallent Pharmaceuticals Health LLC, with additional storage and usage warnings. The label includes barcode and NDC 82009-113-05.*

FDA Label Image

Container50mg (Container50mg)

Label for Metoprolol Succinate Extended-Release Tablets, USP, 50 mg strength, film-coated oral tablets. The package contains 500 tablets. Labeler is Quallent Pharmaceuticals Health LLC. The label includes storage instructions, a warning to keep out of reach of children, and an NDC barcode. Manufactured by Dr. Reddy's Laboratories Limited in India.*

FDA Label Image

Figure (Figure)

A forest plot showing results for subgroups in the MERIT-HF study comparing metoprolol succinate extended-release tablets versus placebo. The three panels depict relative risk and 95% confidence intervals for total mortality, total mortality or all-cause hospitalization, and total mortality or hospitalization for heart failure across various subgroups including geography, NYHA class, ejection fraction ranges, etiology, sex, race, previous myocardial infarction, diabetes mellitus, hypertension status, and heart rate.*

FDA Label Image

Structure (Structure)

Chemical structure of Metoprolol succinate showing the molecular arrangement including benzene ring, hydroxyl group, and succinate moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.